請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/52743
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 林劭品 | |
dc.contributor.author | Chu-Fan Mo | en |
dc.contributor.author | 莫居凡 | zh_TW |
dc.date.accessioned | 2021-06-15T16:25:39Z | - |
dc.date.available | 2018-08-17 | |
dc.date.copyright | 2015-08-17 | |
dc.date.issued | 2015 | |
dc.date.submitted | 2015-08-14 | |
dc.identifier.citation | Draper JS, Smith K, Gokhale P, Moore HD, Maltby E, Johnson J, Meisner L, Zwaka TP, Thomson JA, Andrews PW: Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells. Nature biotechnology 2004, 22(1):53-54.
2. International Stem Cell I, Amps K, Andrews PW, Anyfantis G, Armstrong L, Avery S, Baharvand H, Baker J, Baker D, Munoz MB et al: Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage. Nature biotechnology 2011, 29(12):1132-1144. 3. Silva SS, Rowntree RK, Mekhoubad S, Lee JT: X-chromosome inactivation and epigenetic fluidity in human embryonic stem cells. Proceedings of the National Academy of Sciences of the United States of America 2008, 105(12):4820-4825. 4. Shen Y, Chow J, Wang Z, Fan G: Abnormal CpG island methylation occurs during in vitro differentiation of human embryonic stem cells. Human molecular genetics 2006, 15(17):2623-2635. 5. Allegrucci C, Wu YZ, Thurston A, Denning CN, Priddle H, Mummery CL, Ward-van Oostwaard D, Andrews PW, Stojkovic M, Smith N et al: Restriction landmark genome scanning identifies culture-induced DNA methylation instability in the human embryonic stem cell epigenome. Human molecular genetics 2007, 16(10):1253-1268. 6. Ezashi T, Das P, Roberts RM: Low O2 tensions and the prevention of differentiation of hES cells. Proceedings of the National Academy of Sciences of the United States of America 2005, 102(13):4783-4788. 7. Chen HF, Kuo HC, Chen W, Wu FC, Yang YS, Ho HN: A reduced oxygen tension (5%) is not beneficial for maintaining human embryonic stem cells in the undifferentiated state with short splitting intervals. Human reproduction 2009, 24(1):71-80. 8. Tanasijevic B, Dai B, Ezashi T, Livingston K, Roberts RM, Rasmussen TP: Progressive accumulation of epigenetic heterogeneity during human ES cell culture. Epigenetics : official journal of the DNA Methylation Society 2009, 4(5):330-338. 9. Yang S, Lin G, Tan YQ, Zhou D, Deng LY, Cheng DH, Luo SW, Liu TC, Zhou XY, Sun Z et al: Tumor progression of culture-adapted human embryonic stem cells during long-term culture. Genes, chromosomes & cancer 2008, 47(8):665-679. 10. Kim KP, Thurston A, Mummery C, Ward-van Oostwaard D, Priddle H, Allegrucci C, Denning C, Young L: Gene-specific vulnerability to imprinting variability in human embryonic stem cell lines. Genome research 2007, 17(12):1731-1742. 11. Nishino K, Toyoda M, Yamazaki-Inoue M, Fukawatase Y, Chikazawa E, Sakaguchi H, Akutsu H, Umezawa A: DNA methylation dynamics in human induced pluripotent stem cells over time. PLoS genetics 2011, 7(5):e1002085. 12. Surani MA: Imprinting and the initiation of gene silencing in the germ line. Cell 1998, 93(3):309-312. 13. Reik W, Walter J: Genomic imprinting: parental influence on the genome. Nature reviews Genetics 2001, 2(1):21-32. 14. Bartolomei MS, Webber AL, Brunkow ME, Tilghman SM: Epigenetic mechanisms underlying the imprinting of the mouse H19 gene. Genes & development 1993, 7(9):1663-1673. 15. John RM, Hodges M, Little P, Barton SC, Surani MA: A human p57(KIP2) transgene is not activated by passage through the maternal mouse germline. Human molecular genetics 1999, 8(12):2211-2219. 16. Buiting K, Saitoh S, Gross S, Dittrich B, Schwartz S, Nicholls RD, Horsthemke B: Inherited microdeletions in the Angelman and Prader-Willi syndromes define an imprinting centre on human chromosome 15. Nature genetics 1995, 9(4):395-400. 17. Lucifero D, Mann MR, Bartolomei MS, Trasler JM: Gene-specific timing and epigenetic memory in oocyte imprinting. Human molecular genetics 2004, 13(8):839-849. 18. Dean W, Bowden L, Aitchison A, Klose J, Moore T, Meneses JJ, Reik W, Feil R: Altered imprinted gene methylation and expression in completely ES cell-derived mouse fetuses: association with aberrant phenotypes. Development 1998, 125(12):2273-2282. 19. Zvetkova I, Apedaile A, Ramsahoye B, Mermoud JE, Crompton LA, John R, Feil R, Brockdorff N: Global hypomethylation of the genome in XX embryonic stem cells. Nature genetics 2005, 37(11):1274-1279. 20. Pannetier M, Feil R: Epigenetic stability of embryonic stem cells and developmental potential. Trends in biotechnology 2007, 25(12):556-562. 21. Rugg-Gunn PJ, Ferguson-Smith AC, Pedersen RA: Epigenetic status of human embryonic stem cells. Nature genetics 2005, 37(6):585-587. 22. Baqir S, Smith LC: Growth restricted in vitro culture conditions alter the imprinted gene expression patterns of mouse embryonic stem cells. Cloning and stem cells 2003, 5(3):199-212. 23. Steenman MJ, Rainier S, Dobry CJ, Grundy P, Horon IL, Feinberg AP: Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumour. Nature genetics 1994, 7(3):433-439. 24. Byun HM, Wong HL, Birnstein EA, Wolff EM, Liang G, Yang AS: Examination of IGF2 and H19 loss of imprinting in bladder cancer. Cancer research 2007, 67(22):10753-10758. 25. Cheng YW, Idrees K, Shattock R, Khan SA, Zeng Z, Brennan CW, Paty P, Barany F: Loss of imprinting and marked gene elevation are 2 forms of aberrant IGF2 expression in colorectal cancer. International journal of cancer Journal international du cancer 2010, 127(3):568-577. 26. Liu L, Luo GZ, Yang W, Zhao X, Zheng Q, Lv Z, Li W, Wu HJ, Wang L, Wang XJ et al: Activation of the imprinted Dlk1-Dio3 region correlates with pluripotency levels of mouse stem cells. The Journal of biological chemistry 2010, 285(25):19483-19490. 27. Stadtfeld M, Apostolou E, Akutsu H, Fukuda A, Follett P, Natesan S, Kono T, Shioda T, Hochedlinger K: Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells. Nature 2010, 465(7295):175-181. 28. Pick M, Stelzer Y, Bar-Nur O, Mayshar Y, Eden A, Benvenisty N: Clone- and gene-specific aberrations of parental imprinting in human induced pluripotent stem cells. Stem cells 2009, 27(11):2686-2690. 29. Tierling S, Dalbert S, Schoppenhorst S, Tsai CE, Oliger S, Ferguson-Smith AC, Paulsen M, Walter J: High-resolution map and imprinting analysis of the Gtl2-Dnchc1 domain on mouse chromosome 12. Genomics 2006, 87(2):225-235. 30. Lin SP, Youngson N, Takada S, Seitz H, Reik W, Paulsen M, Cavaille J, Ferguson-Smith AC: Asymmetric regulation of imprinting on the maternal and paternal chromosomes at the Dlk1-Gtl2 imprinted cluster on mouse chromosome 12. Nature genetics 2003, 35(1):97-102. 31. Zhou Y, Cheunsuchon P, Nakayama Y, Lawlor MW, Zhong Y, Rice KA, Zhang L, Zhang X, Gordon FE, Lidov HG et al: Activation of paternally expressed genes and perinatal death caused by deletion of the Gtl2 gene. Development 2010, 137(16):2643-2652. 32. Lin SP, Coan P, da Rocha ST, Seitz H, Cavaille J, Teng PW, Takada S, Ferguson-Smith AC: Differential regulation of imprinting in the murine embryo and placenta by the Dlk1-Dio3 imprinting control region. Development 2007, 134(2):417-426. 33. Kota SK, Lleres D, Bouschet T, Hirasawa R, Marchand A, Begon-Pescia C, Sanli I, Arnaud P, Journot L, Girardot M et al: ICR noncoding RNA expression controls imprinting and DNA replication at the Dlk1-Dio3 domain. Developmental cell 2014, 31(1):19-33. 34. Kagami M, O'Sullivan MJ, Green AJ, Watabe Y, Arisaka O, Masawa N, Matsuoka K, Fukami M, Matsubara K, Kato F et al: The IG-DMR and the MEG3-DMR at human chromosome 14q32.2: hierarchical interaction and distinct functional properties as imprinting control centers. PLoS genetics 2010, 6(6):e1000992. 35. Sutton VR, Shaffer LG: Search for imprinted regions on chromosome 14: comparison of maternal and paternal UPD cases with cases of chromosome 14 deletion. American journal of medical genetics 2000, 93(5):381-387. 36. Kagami M, Sekita Y, Nishimura G, Irie M, Kato F, Okada M, Yamamori S, Kishimoto H, Nakayama M, Tanaka Y et al: Deletions and epimutations affecting the human 14q32.2 imprinted region in individuals with paternal and maternal upd(14)-like phenotypes. Nature genetics 2008, 40(2):237-242. 37. Benetatos L, Vartholomatos G, Hatzimichael E: MEG3 imprinted gene contribution in tumorigenesis. International journal of cancer Journal international du cancer 2011, 129(4):773-779. 38. Zhang X, Gejman R, Mahta A, Zhong Y, Rice KA, Zhou Y, Cheunsuchon P, Louis DN, Klibanski A: Maternally expressed gene 3, an imprinted noncoding RNA gene, is associated with meningioma pathogenesis and progression. Cancer research 2010, 70(6):2350-2358. 39. Zhao J, Dahle D, Zhou Y, Zhang X, Klibanski A: Hypermethylation of the promoter region is associated with the loss of MEG3 gene expression in human pituitary tumors. The Journal of clinical endocrinology and metabolism 2005, 90(4):2179-2186. 40. Haga CL, Phinney DG: MicroRNAs in the imprinted DLK1-DIO3 region repress the epithelial-to-mesenchymal transition by targeting the TWIST1 protein signaling network. The Journal of biological chemistry 2012, 287(51):42695-42707. 41. Kameswaran V, Bramswig NC, McKenna LB, Penn M, Schug J, Hand NJ, Chen Y, Choi I, Vourekas A, Won KJ et al: Epigenetic regulation of the DLK1-MEG3 microRNA cluster in human type 2 diabetic islets. Cell metabolism 2014, 19(1):135-145. 42. Luk JM, Burchard J, Zhang C, Liu AM, Wong KF, Shek FH, Lee NP, Fan ST, Poon RT, Ivanovska I et al: DLK1-DIO3 genomic imprinted microRNA cluster at 14q32.2 defines a stemlike subtype of hepatocellular carcinoma associated with poor survival. The Journal of biological chemistry 2011, 286(35):30706-30713. 43. Manodoro F, Marzec J, Chaplin T, Miraki-Moud F, Moravcsik E, Jovanovic JV, Wang J, Iqbal S, Taussig D, Grimwade D et al: Loss of imprinting at the 14q32 domain is associated with microRNA overexpression in acute promyelocytic leukemia. Blood 2014, 123(13):2066-2074. 44. Gardiner E, Beveridge NJ, Wu JQ, Carr V, Scott RJ, Tooney PA, Cairns MJ: Imprinted DLK1-DIO3 region of 14q32 defines a schizophrenia-associated miRNA signature in peripheral blood mononuclear cells. Molecular psychiatry 2012, 17(8):827-840. 45. Chen HF, Kuo HC, Chien CL, Shun CT, Yao YL, Ip PL, Chuang CY, Wang CC, Yang YS, Ho HN: Derivation, characterization and differentiation of human embryonic stem cells: comparing serum-containing versus serum-free media and evidence of germ cell differentiation. Human reproduction 2007, 22(2):567-577. 46. Huang HP, Yu CY, Chen HF, Chen PH, Chuang CY, Lin SJ, Huang ST, Chan WH, Ueng TH, Ho HN et al: Factors from human embryonic stem cell-derived fibroblast-like cells promote topology-dependent hepatic differentiation in primate embryonic and induced pluripotent stem cells. The Journal of biological chemistry 2010, 285(43):33510-33519. 47. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM: Embryonic stem cell lines derived from human blastocysts. Science 1998, 282(5391):1145-1147. 48. Huang HP, Chen PH, Yu CY, Chuang CY, Stone L, Hsiao WC, Li CL, Tsai SC, Chen KY, Chen HF et al: Epithelial cell adhesion molecule (EpCAM) complex proteins promote transcription factor-mediated pluripotency reprogramming. The Journal of biological chemistry 2011, 286(38):33520-33532. 49. Chen HF, Yu CY, Chen MJ, Chou SH, Chiang MS, Chou WH, Ko BS, Huang HP, Kuo HC, Ho HN: Characteristic expression of major histocompatibility complex and immune privilege genes in human pluripotent stem cells and the derivatives. Cell transplantation 2013. 50. Monk D, Arnaud P, Apostolidou S, Hills FA, Kelsey G, Stanier P, Feil R, Moore GE: Limited evolutionary conservation of imprinting in the human placenta. Proceedings of the National Academy of Sciences of the United States of America 2006, 103(17):6623-6628. 51. Judson H, Hayward BE, Sheridan E, Bonthron DT: A global disorder of imprinting in the human female germ line. Nature 2002, 416(6880):539-542. 52. Monk D, Wagschal A, Arnaud P, Muller PS, Parker-Katiraee L, Bourc'his D, Scherer SW, Feil R, Stanier P, Moore GE: Comparative analysis of human chromosome 7q21 and mouse proximal chromosome 6 reveals a placental-specific imprinted gene, TFPI2/Tfpi2, which requires EHMT2 and EED for allelic-silencing. Genome research 2008, 18(8):1270-1281. 53. Bock C, Reither S, Mikeska T, Paulsen M, Walter J, Lengauer T: BiQ Analyzer: visualization and quality control for DNA methylation data from bisulfite sequencing. Bioinformatics 2005, 21(21):4067-4068. 54. Ginestet C: ggplot2: Elegant Graphics for Data Analysis. J R Stat Soc a Stat 2011, 174:245-245. 55. Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I: Controlling the false discovery rate in behavior genetics research. Behavioural brain research 2001, 125(1-2):279-284. 56. Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, Puigserver P, Carlsson E, Ridderstrale M, Laurila E et al: PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nature genetics 2003, 34(3):267-273. 57. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES et al: Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proceedings of the National Academy of Sciences of the United States of America 2005, 102(43):15545-15550. 58. Ben-Porath I, Thomson MW, Carey VJ, Ge R, Bell GW, Regev A, Weinberg RA: An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nature genetics 2008, 40(5):499-507. 59. Muller FJ, Schuldt BM, Williams R, Mason D, Altun G, Papapetrou EP, Danner S, Goldmann JE, Herbst A, Schmidt NO et al: A bioinformatic assay for pluripotency in human cells. Nature methods 2011, 8(4):315-317. 60. Wyman SK, Knouf EC, Parkin RK, Fritz BR, Lin DW, Dennis LM, Krouse MA, Webster PJ, Tewari M: Post-transcriptional generation of miRNA variants by multiple nucleotidyl transferases contributes to miRNA transcriptome complexity. Genome research 2011, 21(9):1450-1461. 61. Xie P, Sun Y, Ouyang Q, Hu L, Tan Y, Zhou X, Xiong B, Zhang Q, Yuan D, Pan Y et al: Physiological Oxygen Prevents Frequent Silencing of the DLK1-DIO3 Cluster during Human Embryonic Stem Cells Culture. Stem cells 2014, 32(2):391-401. 62. Erceg S, Ronaghi M, Stojkovic M: Human embryonic stem cell differentiation toward regional specific neural precursors. Stem cells 2009, 27(1):78-87. 63. Yuan T, Liao W, Feng NH, Lou YL, Niu X, Zhang AJ, Wang Y, Deng ZF: Human induced pluripotent stem cell-derived neural stem cells survive, migrate, differentiate, and improve neurologic function in a rat model of middle cerebral artery occlusion. Stem cell research & therapy 2013, 4(3):73. 64. Seminatore C, Polentes J, Ellman D, Kozubenko N, Itier V, Tine S, Tritschler L, Brenot M, Guidou E, Blondeau J et al: The postischemic environment differentially impacts teratoma or tumor formation after transplantation of human embryonic stem cell-derived neural progenitors. Stroke; a journal of cerebral circulation 2010, 41(1):153-159. 65. Francis KR, Wei L: Human embryonic stem cell neural differentiation and enhanced cell survival promoted by hypoxic preconditioning. Cell death & disease 2010, 1:e22. 66. Chicha L, Smith T, Guzman R: Stem cells for brain repair in neonatal hypoxia-ischemia. Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 2014, 30(1):37-46. 67. McLaughlin D, Vidaki M, Renieri E, Karagogeos D: Expression pattern of the maternally imprinted gene Gtl2 in the forebrain during embryonic development and adulthood. Gene expression patterns : GEP 2006, 6(4):394-399. 68. Qu C, Jiang T, Li Y, Wang X, Cao H, Xu H, Qu J, Chen JG: Gene expression and IG-DMR hypomethylation of maternally expressed gene 3 in developing corticospinal neurons. Gene expression patterns : GEP 2013, 13(1-2):51-56. 69. Johnson R: Long non-coding RNAs in Huntington's disease neurodegeneration. Neurobiology of disease 2012, 46(2):245-254. 70. Astuti D, Latif F, Wagner K, Gentle D, Cooper WN, Catchpoole D, Grundy R, Ferguson-Smith AC, Maher ER: Epigenetic alteration at the DLK1-GTL2 imprinted domain in human neoplasia: analysis of neuroblastoma, phaeochromocytoma and Wilms' tumour. British journal of cancer 2005, 92(8):1574-1580. 71. Wang P, Ren Z, Sun P: Overexpression of the long non-coding RNA MEG3 impairs in vitro glioma cell proliferation. Journal of cellular biochemistry 2012, 113(6):1868-1874. 72. Kim SH, Yoo BC, Broers JL, Cairns N, Lubec G: Neuroendocrine-specific protein C, a marker of neuronal differentiation, is reduced in brain of patients with Down syndrome and Alzheimer's disease. Biochemical and biophysical research communications 2000, 276(1):329-334. 73. Surmacz B, Noisa P, Risner-Janiczek JR, Hui K, Ungless M, Cui W, Li M: DLK1 promotes neurogenesis of human and mouse pluripotent stem cell-derived neural progenitors via modulating Notch and BMP signalling. Stem cell reviews 2012, 8(2):459-471. 74. Haslinger A, Schwarz TJ, Covic M, Lie DC: Expression of Sox11 in adult neurogenic niches suggests a stage-specific role in adult neurogenesis. The European journal of neuroscience 2009, 29(11):2103-2114. 75. Axell MZ, Zlateva S, Curtis M: A method for rapid derivation and propagation of neural progenitors from human embryonic stem cells. Journal of neuroscience methods 2009, 184(2):275-284. 76. Zhao J, Ohsumi TK, Kung JT, Ogawa Y, Grau DJ, Sarma K, Song JJ, Kingston RE, Borowsky M, Lee JT: Genome-wide identification of polycomb-associated RNAs by RIP-seq. Molecular cell 2010, 40(6):939-953. 77. Kaneko S, Bonasio R, Saldana-Meyer R, Yoshida T, Son J, Nishino K, Umezawa A, Reinberg D: Interactions between JARID2 and noncoding RNAs regulate PRC2 recruitment to chromatin. Molecular cell 2014, 53(2):290-300. 78. Ma H, Morey R, O'Neil RC, He Y, Daughtry B, Schultz MD, Hariharan M, Nery JR, Castanon R, Sabatini K et al: Abnormalities in human pluripotent cells due to reprogramming mechanisms. Nature 2014, 511(7508):177-183. 79. Stadtfeld M, Apostolou E, Ferrari F, Choi J, Walsh RM, Chen T, Ooi SS, Kim SY, Bestor TH, Shioda T et al: Ascorbic acid prevents loss of Dlk1-Dio3 imprinting and facilitates generation of all-iPS cell mice from terminally differentiated B cells. Nature genetics 2012, 44(4):398-405, S391-392. 80. Xu X, Smorag L, Nakamura T, Kimura T, Dressel R, Fitzner A, Tan X, Linke M, Zechner U, Engel W et al: Dppa3 expression is critical for generation of fully reprogrammed iPS cells and maintenance of Dlk1-Dio3 imprinting. Nature communications 2015, 6:6008. 81. Habib O, Habib G, Moon SH, Hong KS, Do JT, Choi Y, Chang SW, Chung HM: Ground-state conditions promote robust Prdm14 reactivation and maintain an active Dlk1-Dio3 region during reprogramming. Molecules and cells 2014, 37(1):31-35. 82. Duggal G, Warrier S, Ghimire S, Broekaert D, Van der Jeught M, Lierman S, Deroo T, Peelman L, Van Soom A, Cornelissen R et al: Alternative Routes to Induce Naive Pluripotency in Human Embryonic Stem Cells. Stem cells 2015. 83. Yu Y, Gao Q, Zhao HC, Li R, Gao JM, Ding T, Bao SY, Zhao Y, Sun XF, Fan Y et al: Ascorbic acid improves pluripotency of human parthenogenetic embryonic stem cells through modifying imprinted gene expression in the Dlk1-Dio3 region. Stem cell research & therapy 2015, 6:69. 84. Chedin F, Lieber MR, Hsieh CL: The DNA methyltransferase-like protein DNMT3L stimulates de novo methylation by Dnmt3a. Proceedings of the National Academy of Sciences of the United States of America 2002, 99(26):16916-16921. 85. Suetake I, Shinozaki F, Miyagawa J, Takeshima H, Tajima S: DNMT3L stimulates the DNA methylation activity of Dnmt3a and Dnmt3b through a direct interaction. The Journal of biological chemistry 2004, 279(26):27816-27823. 86. Kao TH, Liao HF, Wolf D, Tai KY, Chuang CY, Lee HS, Kuo HC, Hata K, Zhang X, Cheng X et al: Ectopic DNMT3L triggers assembly of a repressive complex for retroviral silencing in somatic cells. Journal of virology 2014, 88(18):10680-10695. 87. Tachibana M, Amato P, Sparman M, Gutierrez NM, Tippner-Hedges R, Ma H, Kang E, Fulati A, Lee HS, Sritanaudomchai H et al: Human embryonic stem cells derived by somatic cell nuclear transfer. Cell 2013, 153(6):1228-1238. 88. Chung YG, Eum JH, Lee JE, Shim SH, Sepilian V, Hong SW, Lee Y, Treff NR, Choi YH, Kimbrel EA et al: Human somatic cell nuclear transfer using adult cells. Cell stem cell 2014, 14(6):777-780. 89. Yamada M, Johannesson B, Sagi I, Burnett LC, Kort DH, Prosser RW, Paull D, Nestor MW, Freeby M, Greenberg E et al: Human oocytes reprogram adult somatic nuclei of a type 1 diabetic to diploid pluripotent stem cells. Nature 2014, 510(7506):533-536. 90. Aapola U, Kawasaki K, Scott HS, Ollila J, Vihinen M, Heino M, Shintani A, Kawasaki K, Minoshima S, Krohn K et al: Isolation and initial characterization of a novel zinc finger gene, DNMT3L, on 21q22.3, related to the cytosine-5-methyltransferase 3 gene family. Genomics 2000, 65(3):293-298. 91. Borghese B, Santulli P, Hequet D, Pierre G, de Ziegler D, Vaiman D, Chapron C: Genetic polymorphisms of DNMT3L involved in hypermethylation of chromosomal ends are associated with greater risk of developing ovarian endometriosis. The American journal of pathology 2012, 180(5):1781-1786. 92. Lee SM, Lee YG, Bae JB, Choi JK, Tayama C, Hata K, Yun Y, Seong JK, Kim YJ: HBx induces hypomethylation of distal intragenic CpG islands required for active expression of developmental regulators. Proceedings of the National Academy of Sciences of the United States of America 2014, 111(26):9555-9560. 93. El-Maarri O, Kareta MS, Mikeska T, Becker T, Diaz-Lacava A, Junen J, Nusgen N, Behne F, Wienker T, Waha A et al: A systematic search for DNA methyltransferase polymorphisms reveals a rare DNMT3L variant associated with subtelomeric hypomethylation. Human molecular genetics 2009, 18(10):1755-1768. 94. Haggarty P, Hoad G, Harris SE, Starr JM, Fox HC, Deary IJ, Whalley LJ: Human intelligence and polymorphisms in the DNA methyltransferase genes involved in epigenetic marking. PloS one 2010, 5(6):e11329. 95. Saradalekshmi KR, Neetha NV, Sathyan S, Nair IV, Nair CM, Banerjee M: DNA methyl transferase (DNMT) gene polymorphisms could be a primary event in epigenetic susceptibility to schizophrenia. PloS one 2014, 9(5):e98182. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/52743 | - |
dc.description.abstract | 選擇優質的人類胚胎幹細胞株 (human embryonic stem cell lines, hESCs lines) 對於 hESC 相關的研究及治療模式能否成功是關鍵的。然而, 在 hESC 的培養中經常能觀察到一些基因或表觀基因修飾的不穩定,包括基因銘印不穩定等現象。經由銘印機制調控的銘印基因當其表現失調時被認為與許多生長缺陷及癌症發生相關。我們利用 bisulfite 定序技術發現 DLK1-DIO3 銘印區域相較於其它受測區域更容易在長期培養的 hESC 中遭受異常的高度甲基化修飾。此外,源自該銘印區域經母源表現之非編碼 RNA (non-coding RNAs) 其表現在長期培養的 hESC 中遭受到抑制也為一相關異常。為了探討該銘印區域是否與 hESC 細胞特性有關,本研究主要依據該區域中名為 MEG3 長片段非編碼 RNA (lncRNA) 與其下游之 lncRNA 及微 RNA (microRNA, miRNA) 之表現,將 hESC 亞細胞株分為 “MEG3-ON” 與 “MEG3-OFF” 兩組。與 MEG3-ON 組別相比,這些 ncRNA 的表現在 MEG3-OFF 組別受到抑制。初步分化 hESC 為類胚體 (Embyoid body, EB) 的實驗結果顯示,由 MEG3-OFF hESC 衍生出的第十二天的 EB 其形態不正常且三胚層相關的基因表現異常。轉錄組分析顯示,與 MEG3-ON 組別相比,許多與發育及癌症相關的基因在 MEG3-OFF 組別中表現失調。特別的是,大部份的失調基因與神經系統有關。我們在數種 hESC 細胞株與誘發性多潛能幹細胞 (hiPSC) 株中驗證了 MEG3 失去表現的確與一些神經系相關的基因受到調降有關,之後利用 siRNA 及 shRNA 方式調降 MEG3 表現後同樣偵測到這些基因的表現降低。藉由神經分化的實驗證明,與 MEG3-ON hESC 所分化的類神經系細胞相比,將 MEG3-OFF hESC 誘導分化成類神經系細胞後,階段性的神經標記表現較低,且神經軸突的形成較少。因此,本研究推論避免使用 DLK1-DIO3 銘印區域失調的 MEG3-OFF hESC 能維持具備較好的神經分化潛能的實驗效率,其對於在基礎研究與進一步的治療應用將有所助益。 | zh_TW |
dc.description.abstract | Selection of high-quality human embryonic stem cell (hESC) lines is crucial for successful hESC-based research and therapeutic models; however, some genetic and epigenetic instability, including imprinting instability, have been frequently found in cultured hESCs. Imprinted genes should be correctly regulated by Epigenetic machinery. Defective dosages of imprinted gene expression are associated with various growth defects and cancers. When screening the imprinting status in prolonged cultured hESCs by bisulfite sequencing, we observed that the DLK1-DIO3 imprinted locus was more susceptible to abnormal hypermethylation than other examined imprinted loci. Also, repression of maternally expressed non-coding RNAs (ncRNAs) from this locus was one of the first signs of epigenetic deregulation in the prolonged cultured hESCs. To investigate whether this locus correlates with hESC properties, we classified hESC sublines into “MEG3-ON” and “MEG3-OFF” primarily based on the expression levels of a long non-coding RNA from this locus (lncRNA), named MEG3, as well as its down-stream lncRNA and microRNAs (miRNAs). Through embryoid body (EB) formation, we found that the 12-Day-old EBs derived from MEG3-OFF hESCs, where DLK1-DIO3 ncRNAs were repressed, displayed smaller size and aberrant expressions of three germ layer genes. Transcriptome profiling showed that many genes involved in developmental events and different cancer types were deregulated in undifferentiated MEG3-OFF hESCs, compared with MEG3-ON hESCs. Notably, most of these deregulated genes are associated with neural lineage. When validating array results in three hESC lines and two hiPSC lines, we found an association between MEG3 repression and downregulation of several neural lineage-related genes. Direct manipulation of MEG3 via siRNA and shRNA knockdown approach further suggested a potential causative effect that MEG3 reduction leads to a decrease in these neural lineage gene expressions. When performing neural differentiation, lower expression levels of stage-specific neural lineage markers and reduced neurite formation were observed in the neural lineage-like cells derived from MEG3-OFF hESCs compared with those in MEG3-ON groups. Taken together, this study suggested that prevention of using MEG3-OFF hESCs where DLK1-DIO3 locus was deregulated may maintain the experimental efficiency with proper neural differentiation potential, which will benefit basic research and further therapeutic applications in this field. | en |
dc.description.provenance | Made available in DSpace on 2021-06-15T16:25:39Z (GMT). No. of bitstreams: 1 ntu-104-D98642005-1.pdf: 6144327 bytes, checksum: f538b30a2b1036a065ee23c4f8c70dbc (MD5) Previous issue date: 2015 | en |
dc.description.tableofcontents | 致謝....................................................................................................................................1
中文摘要............................................................................................................................2 ABSTRACT......................................................................................................................4 CONTENTS......................................................................................................................7 LIST OF FIGURES.........................................................................................................12 LIST OFTABLES...........................................................................................................14 ABBREVIATIONS.........................................................................................................15 CHAPTER ONE General introduction........................................................................................................17 1. The general instabilities found in human embryonic stem cell lines..................18 2. Imprinting instabilities in embryonic stem cell lines .........................................19 2.1. Genomic imprinting..........................................................................................19 2.2. Deregulation of several imprinted regions in ESC lines..................................20 3. Imprinting instability of Dlk1-Dio3 locus in pluripotent stem cells....................21 4. The Dlk-Dio3 imprinted locus and its epigenetic regulatory mechanism...........22 5. The defects of DLK1-DIO3 imprinted locus in humans.....................................24 5.1. Implications of regulatory mechanisms of human DLK1-DIO3 locus from the patients with different mutations on this locus........................................................24 5.2. Pathological symptoms related to the defective DLK1-DIO3 locus................24 CHAPTER TWO Study I: DLK1-DIO3 imprinted locus may serve as one of appropriate markers for differentiating hESC properties ......................................................................................27 1.Introduction..........................................................................................................28 2. Materials and Methods .......................................................................................30 3. Results.................................................................................................................39 3.1. The DLK1-DIO3 locus was more susceptible to imprinting instability than the other examined loci in cultured hESC lines ...........................................................39 3.2. Classification of MEG3-ON and MEG3-OFF hESC sublines.........................40 3.3. Embryoid bodies (EBs) derived from MEG3-OFF hESCs showed abnormal morphologies and aberrant gene expression levels of the three embryonic germ layers.......................................................................................................................41 3.4. Undifferentiated MEG3-OFF hESCs displayed a different transcriptome profile from MEG3-ON hESCs, particularly in the genes involving in development and cancers..............................................................................................................42 4. Discussion & Conclusion....................................................................................44 CHAPTER THREE Study II: Deregulation of DLK1-DIO3 imprinted locus correlates with reduced neural differentiation potential in human embryonic stem cell lines.........................................58 1. Introduction.........................................................................................................59 1.1 Therapeutic potential of hESCs in animal neurological disease models and its obstacles..................................................................................................................59 1.2. Meg3/MEG3 lncRNA and other miRNAs derived from the DLK1-DIO3 locus are relative to nervous system development and associated diseases ..................60 1.3. The implications from Chapter Two ................................................................60 2. Materials and Methods .......................................................................................62 3.Results..................................................................................................................65 3.1. Validation of the associations between the MEG3 repression and some neural lineage gene expression levels in undifferentiated hESCs......................................65 3.2. MEG3-OFF hESC-derived neural-lineage-like cells showed lower expression levels of neural lineage markers ...........................................................................66 3.3. MEG3-OFF hESC-derived neural-lineage-like cells showed reduced neurite formation.................................................................................................................67 4. Discussion & Conclusion ...................................................................................69 CHAPTER FOUR General discussion & Summary......................................................................................85 1. General discussion...............................................................................................86 2. Summary..............................................................................................................92 REFERENCES................................................................................................................99 APPENDIX...................................................................................................................121 Appendix 1: Total protein levels of H3K4me3, H3K9me3 and H3K27me3 in NTU1 MEG3-ON and MEG3-OFF hESC sublines...........................................................................................122 Appendix 2: Curriculum Vitae...........................................................................................................123 Appendix 3: Published paper.............................................................................................................128 Appendix 3.1. Dnmt3l-knockout donor cells improve somatic cell nuclear transfer reprogramming efficiency. Appendix 3.2. Loss of non-coding RNA expression from the DLK1-DIO3 imprinted locus correlates with reduced neural differentiation potential in human embryonic stem cell lines Appendix 3.3. Epigenetic factors in the regulation of prospermatogonia and spermatogonial stem cells | |
dc.language.iso | en | |
dc.title | DLK1-DIO3 基因體銘印區域基因表現與人類胚胎幹細胞株分化潛能之關聯性 | zh_TW |
dc.title | Epigenetic deregulation of DLK-DIO3 imprinted locus and the differentiation potential of human embryonic stem cells | en |
dc.type | Thesis | |
dc.date.schoolyear | 103-2 | |
dc.description.degree | 博士 | |
dc.contributor.oralexamcommittee | 陳信孚,宋麗英,黃憲松,陳俊安 | |
dc.subject.keyword | 非編碼 RNA,DLK1-DIO3 基因體銘印區域,人類胚胎幹細胞,神經系分化,MEG3 長片段非編碼 RNA,微 RNA,軸突形成, | zh_TW |
dc.subject.keyword | Non-coding RNA,DLK1-DIO3 imprinted locus,human embryonic stem cell,neural lineage differentiation,MEG3,long non-coding RNA,microRNA,neurite formation, | en |
dc.relation.page | 174 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2015-08-14 | |
dc.contributor.author-college | 生物資源暨農學院 | zh_TW |
dc.contributor.author-dept | 生物科技研究所 | zh_TW |
顯示於系所單位: | 生物科技研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-104-1.pdf 目前未授權公開取用 | 6 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。